Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options

BACKGROUND: Immune checkpoint inhibitor (ICI) treatment has become important for treating various cancer types, including metastatic renal cell carcinoma. However, ICI treatment can lead to endocrine immune-related adverse events (irAEs) by overstimulating the patient’s immune system. Here, we repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Daetwyler, Eveline, Zippelius, Alfred, Danioth, Simona, Donath, Marc Y., Gut, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640970/
https://www.ncbi.nlm.nih.gov/pubmed/37965350
http://dx.doi.org/10.3389/fimmu.2023.1248919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640970/
https://www.ncbi.nlm.nih.gov/pubmed/37965350
http://dx.doi.org/10.3389/fimmu.2023.1248919

Ejemplares similares